TLDR
- CBRS shares have retreated significantly from the post-IPO peak of $300, hovering near $211 during Monday’s premarket session
- Six Wall Street firms launched coverage Monday with positive ratings and price objectives between $250 and $300
- The AI chip company boasts a $24.6 billion backlog in contracted revenue, driven primarily by OpenAI and AWS partnerships
- Cerebras’ Wafer-Scale Engine represents the world’s largest commercially available chip, designed for rapid AI inference tasks
- Trailing twelve-month revenue reached $510 million with 76% year-over-year expansion, though valuation sits at a steep 225x earnings ratio
Cerebras Systems experienced a wild initial public offering. The artificial intelligence chip manufacturer debuted on public markets last month, with shares rocketing beyond $300 almost instantaneously before retreating substantially.
Shares were changing hands around $211.80 during Monday’s premarket trading, representing a 5.4% intraday gain while remaining far below those initial peaks. The preceding week witnessed a 6.7% decline as semiconductor stocks broadly faced selling pressure.
Now, a coordinated wave of analyst coverage is emerging — and the Street believes the current valuation presents an opportunity.
Mizuho analyst Vijay Rakesh launched coverage with an Outperform designation and $300 price objective. Matt Bryson from Wedbush initiated with a Buy rating alongside a $270 target. Barclays assigned an overweight stance with a $280 forecast. Both UBS and Rosenblatt established $300 targets. Morgan Stanley took the most cautious approach among the group, starting coverage at overweight with a $250 price goal.
That represents considerable optimism from Wall Street within a single trading session.
What Makes Cerebras Different
The foundation of the bullish thesis centers on the chip technology. Cerebras manufactures what’s known as a Wafer-Scale Engine — effectively the largest semiconductor chip ever brought to commercial markets. The design is purpose-built for AI inference operations, which involve deploying trained models to produce results.
Contrary to Nvidia’s methodology, which connects thousands of smaller GPU units through sophisticated networking infrastructure, Cerebras consolidates everything onto a single enormous chip. This approach eliminates substantial overhead and enables accelerated token generation speeds.
“With the industry focused on inference to deliver Agentic AI solutions, we see Cerebras well-positioned as the industry leader in fast inference,” Mizuho’s Rakesh wrote.
Wedbush characterized the architecture as differentiated and observed that the market is “now learning to pay for speed” in AI inference.
The Backlog — and the Concentration Risk
Cerebras disclosed a revenue backlog totaling $24.6 billion at the close of 2025. That figure commands attention. But there’s a caveat: the majority stems from a single agreement with OpenAI.
This customer concentration has raised concerns among certain investors. Nevertheless, the company secured a separate contract with Amazon Web Services, which introduces another prominent customer and provides some reassurance regarding revenue diversification.
Wedbush’s Bryson characterized it this way: “With a differentiated architecture, a step-change in contracted revenue from OpenAI and AWS, and a market only now learning to pay for speed, we see an asymmetric, upside-skewed setup.”
His $270 price target derives from 40 times his projected 2028 earnings estimate, adjusted for net cash position.
Trailing twelve-month revenue totaled $510 million, reflecting 76% year-over-year growth. The stock commands a 225x earnings multiple, which InvestingPro identified as elevated relative to fair value.
At Monday’s premarket level near $211, CBRS had climbed approximately 14% during the session by mid-morning hours, according to refreshed trading data.





